Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 1, 2016
March 14, 2019
66ca6a85-aebe-4b20-a0ba-d0f7e4e393d3
Related Documents
Validation of Procedures for Processing of Human Tissues Intended for Transplantation: Guidance for Industry
Guidance DocumentMarch 8, 2002Center for Biologics Evaluation and Research
Revised Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products Who Have Received Human-Derived Clotting Factor Concentrates: Guidance for Industry
Guidance DocumentNovember 1, 2016Center for Biologics Evaluation and Research
Biological Product Deviation Reporting for Blood and Plasma Establishments: Guidance for Industry
Guidance DocumentMarch 12, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.